David McNamara: Weight loss drugs are expanding Ireland’s trade balance
The surge in global demand for weight loss drugs could underpin Irish pharmaceuticals exports, such as Eli Lilly, in the near term, and maybe offset some of the negative effects of US tariffs in other sectors.
The latest Irish GDP data provided the first full breakdown of the economy in Q2 2025.
GDP growth remains volatile (+0.2% q/q, +17% y/y), driven by a surge in exports in the first half of the year due to tariff frontrunning and the emergence of pharma production of weight loss drugs in Ireland.
